Core Insights - Conestoga Capital Advisors reported that equity markets reached new all-time highs in Q3 2025, but the Conestoga Small Cap Composite underperformed the Russell 2000 Growth Index, returning -1.4% compared to the Index's 12.2% gain [1] - The gains in the Russell 2000 Growth Index were primarily driven by low-quality stocks, particularly unprofitable, high-beta names [1] Company Highlights: Mirion Technologies, Inc. (NYSE:MIR) - Mirion Technologies, Inc. specializes in radiation detection, measurement, analysis, and monitoring products for medical and nuclear safety applications [2][3] - The stock of Mirion Technologies gained 1.30% over the past month and 71.94% over the last 52 weeks, closing at $24.17 with a market capitalization of $6.053 billion on October 17, 2025 [2] - The company benefits from durable demand drivers such as increased focus on nuclear energy, healthcare imaging, and global safety standards, generating recurring revenue through service contracts and consumables [3] Financial Performance - In Q2 2025, Mirion Technologies reported revenue of $222.9 million, reflecting a year-over-year increase of 7.6% [4] - The number of hedge funds holding Mirion Technologies increased from 35 to 46 in the second quarter of 2025, indicating growing interest among institutional investors [4] Investment Outlook - Mirion Technologies is viewed as having attractive growth potential due to improving margins, deleveraging progress, and exposure to long-term infrastructure and energy trends [3] - Despite the potential of Mirion Technologies, the company is not considered among the top 30 most popular stocks among hedge funds, and there are suggestions that certain AI stocks may offer greater upside potential with less downside risk [4]
Does Mirion Technologies (MIR) Have an Attractive Growth Potential?